伴骨髓受累的儿童成熟B细胞急性淋巴细胞白血病与非霍奇金淋巴瘤的临床和分子特征:中国儿童肿瘤协作组白血病与淋巴瘤组的联合研究
该研究纳入156例中国儿童肿瘤协作组中骨髓原始细胞>5%且免疫表型符合成熟B细胞的患儿,不区分成熟B细胞急性淋巴细胞白血病与非霍奇金淋巴瘤骨髓浸润。2年无进展生存、无事件生存和总生存分别为76.6±3.6%、69.7±3.7%和80.1±3.3%。中枢神经系统受累、血清铁蛋白高于正常4倍和利妥昔单抗不超过2剂与较低无进展生存相关。
要点
- 2年无进展生存76.6±3.6%,2年无事件生存69.7±3.7%,2年总生存80.1±3.3%。
- 中枢神经系统受累、血清铁蛋白高于正常4倍和利妥昔单抗不超过2剂与较低无进展生存相关。
- 男性、巨块型病变和头颈部区域受累与更高的中枢神经系统侵犯率相关。
核心结论
- 伴骨髓受累的成熟B细胞急性淋巴细胞白血病/非霍奇金淋巴瘤在临床特征和遗传学改变上均为异质性恶性肿瘤。
- 遗传学分析有助于作出准确诊断并指导适当的治疗策略。
研究设计与样本
- 中国儿童肿瘤协作组白血病与淋巴瘤组的联合研究,纳入156例骨髓原始细胞>5%且免疫表型符合成熟B细胞的患儿。
- 对36例进行了整合转录组学分析。
主要发现
- 2年无进展生存为76.6±3.6%,2年无事件生存为69.7±3.7%,2年总生存为80.1±3.3%。
- 中枢神经系统受累、血清铁蛋白高于正常4倍和利妥昔单抗不超过2剂与较低无进展生存相关。
- 男性、巨块型病变和头颈部区域受累与更高的中枢神经系统侵犯率相关。
- 结构变异包括IG::MYC、IGH::CACS11、MEF2D::BCL9、IGH::VPS53和ACIN1::NUTM1。
- 单核苷酸变异分析发现10个反复突变基因的驱动变异,包括ID3、TP53、MYC、ARID1A、SMARCA4、DDX3X、CCND3、RHOA、SMARCB1、FOXO1和GNA13。
临床怎么用
- 作者认为遗传学分析有助于作出准确诊断并指导适当的治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mature B-cell acute lymphocytic leukaemia (B-ALL) is distinguished from B-cell non-Hodgkin lymphoma (B-NHL) by the arbitrariness of the 25% cut-off, and given that the percentage of bone marrow (BM) blasts can vary according to site of aspirate, we refrained from differentiating mature B-ALL from B-NHL with BM infiltration. A total of 156 patients from the Chinese Children Cancer Group with BM blasts of more than 5% and consistent with immunophenotypic features of mature B cells were included in this study. The 2-year progression-free survival, 2-year event-free survival and 2-year overall survival were 76.6 ± 3.6%, 69.7 ± 3.7% and 80.1 ± 3.3% respectively. Central nervous system (CNS) involvement, serum ferritin levels higher than four times normal and rituximab no more than two doses were associated with lower PFS. Male, bulky disease and head/neck region involvement were associated with higher rate of CNS invasion. We performed an integrative transcriptomic characterization of 36 cases. Structure variant included IG::MYC, IGH::CACS11, MEF2D::BCL9, IGH::VPS53 and ACIN1::NUTM1. SNV analysis uncovered driver variations affecting 10 recurrently mutated genes including ID3, TP53, MYC, ARID1A, SMARCA4, DDX3X, CCND3, RHOA, SMARCB1, FOXO1 and GNA13. Mature B-ALL/B-NHL with BM involvement was a heterogeneous group of malignancies in both clinical features and genetic alternations. Genetics analysis was helpful for making accurate diagnoses and guiding appropriate therapeutic strategies.
引用
- Zhao J, Liu TF, Wu KF, et al. Clinical and molecular characteristics of paediatric mature B-cell acute lymphocytic leukaemia and non-Hodgkin lymphoma with bone marrow involvement: A joint study between the CCCG leukaemia and lymphoma groups. Br J Haematol. 2025. PMID: 39962993. doi:10.1111/bjh.20011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。